RLAY News and Press, Relay Therapeutics Inc. From 05/10/24

2024-05-10 11:13:46 ET More on Relay Therapeutics Relay Therapeutics: Platform More Important Than Programs Relay Therapeutics: Tapping Into An Unmet Need At A High Price Tag Relay Therapeutics GAAP EPS of -$0.62 beats by $0.10, revenue of $10.01M beats by $9.09M ...

2024-05-06 09:15:03 ET Oppenheimer analyst issues OUTPERFORM recommendation for RLAY on May 6, 2024 07:53AM ET. The previous analyst recommendation was Outperform. RLAY was trading at $7.04 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2024-05-03 01:41:11 ET More on Relay Therapeutics Relay Therapeutics: Platform More Important Than Programs Relay Therapeutics: Tapping Into An Unmet Need At A High Price Tag Seeking Alpha’s Quant Rating on Relay Therapeutics Historical earnings data f...

2024-05-02 16:25:12 ET More on Relay Therapeutics Relay Therapeutics: Platform More Important Than Programs Relay Therapeutics: Tapping Into An Unmet Need At A High Price Tag Seeking Alpha’s Quant Rating on Relay Therapeutics Historical earnings data f...

CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today reported first quarter 2024 financia...

CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report first quarter 2024 financial res...

2024-04-24 06:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-14 08:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will partici...

2024-04-10 17:20:42 ET Gainers: Rallybio Corporation ( RLYB ) +42% . Alpine Immune Sciences ( ALPN ) +36% . Vera Therapeutics ( VERA ) +10% . Relay Therapeutics ( RLAY ) +7% . Olema Pharmaceuticals  ( OLMA ) +5% . Lose...